243 related articles for article (PubMed ID: 22869525)
1. Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase β and the IGF-I receptor to regulate IGF-I-stimulated signaling.
Shen X; Xi G; Maile LA; Wai C; Rosen CJ; Clemmons DR
Mol Cell Biol; 2012 Oct; 32(20):4116-30. PubMed ID: 22869525
[TBL] [Abstract][Full Text] [Related]
2. The coordinate cellular response to insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding protein-2 (IGFBP-2) is regulated through vimentin binding to receptor tyrosine phosphatase β (RPTPβ).
Shen X; Xi G; Wai C; Clemmons DR
J Biol Chem; 2015 May; 290(18):11578-90. PubMed ID: 25787077
[TBL] [Abstract][Full Text] [Related]
3. IRS-1 Functions as a Molecular Scaffold to Coordinate IGF-I/IGFBP-2 Signaling During Osteoblast Differentiation.
Xi G; Shen X; Rosen CJ; Clemmons DR
J Bone Miner Res; 2016 Jun; 31(6):1300-14. PubMed ID: 26773517
[TBL] [Abstract][Full Text] [Related]
4. Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins.
Hsieh T; Gordon RE; Clemmons DR; Busby WH; Duan C
J Biol Chem; 2003 Oct; 278(44):42886-92. PubMed ID: 12917428
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte antigen-related deficiency enhances insulin-like growth factor-1 signaling in vascular smooth muscle cells and promotes neointima formation in response to vascular injury.
Niu XL; Li J; Hakim ZS; Rojas M; Runge MS; Madamanchi NR
J Biol Chem; 2007 Jul; 282(27):19808-19. PubMed ID: 17500057
[TBL] [Abstract][Full Text] [Related]
6. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
Ricort JM; Binoux M
Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-binding protein-2 is required for osteoclast differentiation.
DeMambro VE; Maile L; Wai C; Kawai M; Cascella T; Rosen CJ; Clemmons D
J Bone Miner Res; 2012 Feb; 27(2):390-400. PubMed ID: 22006816
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
10. IGFBP-2 directly stimulates osteoblast differentiation.
Xi G; Wai C; DeMambro V; Rosen CJ; Clemmons DR
J Bone Miner Res; 2014 Nov; 29(11):2427-38. PubMed ID: 24839202
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
Moralez AM; Maile LA; Clarke J; Busby WH; Clemmons DR
J Cell Physiol; 2005 May; 203(2):328-34. PubMed ID: 15700281
[TBL] [Abstract][Full Text] [Related]
12. p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment.
Xi G; Shen X; Clemmons DR
Mol Endocrinol; 2008 Sep; 22(9):2162-75. PubMed ID: 18606861
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.
Radhakrishnan Y; Busby WH; Shen X; Maile LA; Clemmons DR
J Biol Chem; 2010 May; 285(21):15682-95. PubMed ID: 20207740
[TBL] [Abstract][Full Text] [Related]
14. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical effects of the phage display-derived peptide antagonist IGF-F1-1 on insulin-like growth factor-1 receptor signaling.
Robinson SA; Rosenzweig SA
Biochem Pharmacol; 2006 Jun; 72(1):53-61. PubMed ID: 16684509
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-binding protein-5 stimulates growth of human intestinal muscle cells by activation of G{alpha}i3.
Flynn RS; Mahavadi S; Murthy KS; Kellum JM; Kuemmerle JF
Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1232-8. PubMed ID: 19808657
[TBL] [Abstract][Full Text] [Related]
17. Involvement of ligand occupancy in Insulin-like growth factor-I (IGF-I) induced cell growth in osteoblast like MC3T3-E1 cells.
Kim SK; Kwon JY; Nam TJ
Biofactors; 2007; 29(4):187-202. PubMed ID: 18057550
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.
Pukac L; Huangpu J; Karnovsky MJ
Exp Cell Res; 1998 Aug; 242(2):548-60. PubMed ID: 9683541
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate chondrocytes.
Kiepe D; Ulinski T; Powell DR; Durham SK; Mehls O; Tönshoff B
Kidney Int; 2002 Nov; 62(5):1591-600. PubMed ID: 12371959
[TBL] [Abstract][Full Text] [Related]
20. Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells.
Li M; Chiu JF; Gagne J; Fukagawa NK
J Cell Physiol; 2008 Nov; 217(2):377-87. PubMed ID: 18615585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
